Review of methodological problems in the interpretation of phase II trials in nonsmall-cell lung cancer.
Sørensen
J B
JB
Department of Oncology ONB, Finsen Institute, Copenhagen, Denmark.
Hansen
H H
HH
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D012107:Research Design